ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) Stock Fundamental Analysis

NASDAQ:ZBRA • US9892071054

264.62 USD
-9.53 (-3.48%)
At close: Feb 13, 2026
264.62 USD
0 (0%)
After Hours: 2/13/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

5

ZBRA gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 123 industry peers in the Electronic Equipment, Instruments & Components industry. While ZBRA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ZBRA is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make ZBRA suitable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year ZBRA was profitable.
  • ZBRA had a positive operating cash flow in the past year.
  • Of the past 5 years ZBRA 4 years were profitable.
  • The reported operating cash flow has been mixed in the past 5 years: ZBRA reported negative operating cash flow in multiple years.
ZBRA Yearly Net Income VS EBIT VS OCF VS FCFZBRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

1.2 Ratios

  • ZBRA has a Return On Assets of 6.35%. This is in the better half of the industry: ZBRA outperforms 78.86% of its industry peers.
  • Looking at the Return On Equity, with a value of 13.66%, ZBRA belongs to the top of the industry, outperforming 81.30% of the companies in the same industry.
  • ZBRA has a better Return On Invested Capital (10.71%) than 87.80% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ZBRA is above the industry average of 8.97%.
Industry RankSector Rank
ROA 6.35%
ROE 13.66%
ROIC 10.71%
ROA(3y)5.61%
ROA(5y)7.93%
ROE(3y)13.8%
ROE(5y)18.59%
ROIC(3y)11.59%
ROIC(5y)14.22%
ZBRA Yearly ROA, ROE, ROICZBRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1.3 Margins

  • With an excellent Profit Margin value of 9.74%, ZBRA belongs to the best of the industry, outperforming 82.11% of the companies in the same industry.
  • In the last couple of years the Profit Margin of ZBRA has declined.
  • ZBRA has a Operating Margin of 15.34%. This is amongst the best in the industry. ZBRA outperforms 89.43% of its industry peers.
  • In the last couple of years the Operating Margin of ZBRA has remained more or less at the same level.
  • With an excellent Gross Margin value of 48.39%, ZBRA belongs to the best of the industry, outperforming 83.74% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ZBRA has remained more or less at the same level.
Industry RankSector Rank
OM 15.34%
PM (TTM) 9.74%
GM 48.39%
OM growth 3Y-5.09%
OM growth 5Y-0.99%
PM growth 3Y-10.68%
PM growth 5Y-2.66%
GM growth 3Y1.23%
GM growth 5Y0.68%
ZBRA Yearly Profit, Operating, Gross MarginsZBRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ZBRA is still creating some value.
  • ZBRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ZBRA Yearly Shares OutstandingZBRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ZBRA Yearly Total Debt VS Total AssetsZBRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • ZBRA has an Altman-Z score of 3.89. This indicates that ZBRA is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 3.89, ZBRA is in the better half of the industry, outperforming 64.23% of the companies in the same industry.
  • The Debt to FCF ratio of ZBRA is 2.74, which is a good value as it means it would take ZBRA, 2.74 years of fcf income to pay off all of its debts.
  • ZBRA has a Debt to FCF ratio of 2.74. This is in the better half of the industry: ZBRA outperforms 72.36% of its industry peers.
  • A Debt/Equity ratio of 0.56 indicates that ZBRA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.56, ZBRA is doing worse than 75.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.74
Altman-Z 3.89
ROIC/WACC1.19
WACC9.01%
ZBRA Yearly LT Debt VS Equity VS FCFZBRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • ZBRA has a Current Ratio of 1.61. This is a normal value and indicates that ZBRA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.61, ZBRA is doing worse than 70.73% of the companies in the same industry.
  • ZBRA has a Quick Ratio of 1.19. This is a normal value and indicates that ZBRA is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.19, ZBRA is doing worse than 69.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.61
Quick Ratio 1.19
ZBRA Yearly Current Assets VS Current LiabilitesZBRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 17.25% over the past year.
  • The Earnings Per Share has been growing slightly by 4.34% on average over the past years.
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.57%

3.2 Future

  • The Earnings Per Share is expected to grow by 17.27% on average over the next years. This is quite good.
  • ZBRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.65% yearly.
EPS Next Y12.75%
EPS Next 2Y11.66%
EPS Next 3Y14.19%
EPS Next 5Y17.27%
Revenue Next Year9.76%
Revenue Next 2Y7.61%
Revenue Next 3Y6.32%
Revenue Next 5Y11.65%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZBRA Yearly Revenue VS EstimatesZBRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
ZBRA Yearly EPS VS EstimatesZBRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 16.71, ZBRA is valued correctly.
  • ZBRA's Price/Earnings ratio is rather cheap when compared to the industry. ZBRA is cheaper than 84.55% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.68, ZBRA is valued a bit cheaper.
  • ZBRA is valuated correctly with a Price/Forward Earnings ratio of 14.82.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ZBRA indicates a rather cheap valuation: ZBRA is cheaper than 85.37% of the companies listed in the same industry.
  • ZBRA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE 16.71
Fwd PE 14.82
ZBRA Price Earnings VS Forward Price EarningsZBRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ZBRA is valued a bit cheaper than the industry average as 76.42% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, ZBRA is valued cheaper than 86.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 16.93
EV/EBITDA 14.91
ZBRA Per share dataZBRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • ZBRA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • ZBRA has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ZBRA's earnings are expected to grow with 14.19% in the coming years.
PEG (NY)1.31
PEG (5Y)3.85
EPS Next 2Y11.66%
EPS Next 3Y14.19%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ZBRA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZEBRA TECHNOLOGIES CORP-CL A

NASDAQ:ZBRA (2/13/2026, 8:00:02 PM)

After market: 264.62 0 (0%)

264.62

-9.53 (-3.48%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-12
Earnings (Next)05-12
Inst Owners98.81%
Inst Owner Change-92.29%
Ins Owners0.7%
Ins Owner Change1.58%
Market Cap13.41B
Revenue(TTM)N/A
Net Income(TTM)512.00M
Analysts79.23
Price Target343.38 (29.76%)
Short Float %2.8%
Short Ratio2.27
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.94%
Min EPS beat(2)1.41%
Max EPS beat(2)6.47%
EPS beat(4)3
Avg EPS beat(4)4.07%
Min EPS beat(4)-0.59%
Max EPS beat(4)8.97%
EPS beat(8)7
Avg EPS beat(8)6.01%
EPS beat(12)9
Avg EPS beat(12)4.27%
EPS beat(16)12
Avg EPS beat(16)3.16%
Revenue beat(2)0
Avg Revenue beat(2)-1.47%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)-1.45%
Revenue beat(4)0
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)-0.61%
Revenue beat(8)3
Avg Revenue beat(8)-0.33%
Revenue beat(12)5
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-1.18%
PT rev (1m)-5.46%
PT rev (3m)-9.51%
EPS NQ rev (1m)-0.02%
EPS NQ rev (3m)0.13%
EPS NY rev (1m)0.2%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.15%
Valuation
Industry RankSector Rank
PE 16.71
Fwd PE 14.82
P/S 2.55
P/FCF 16.93
P/OCF 15.48
P/B 3.58
P/tB N/A
EV/EBITDA 14.91
EPS(TTM)15.84
EY5.99%
EPS(NY)17.86
Fwd EY6.75%
FCF(TTM)15.63
FCFY5.91%
OCF(TTM)17.09
OCFY6.46%
SpS103.73
BVpS73.96
TBVpS-11.05
PEG (NY)1.31
PEG (5Y)3.85
Graham Number162.36
Profitability
Industry RankSector Rank
ROA 6.35%
ROE 13.66%
ROCE 12.47%
ROIC 10.71%
ROICexc 12.79%
ROICexgc 62.7%
OM 15.34%
PM (TTM) 9.74%
GM 48.39%
FCFM 15.07%
ROA(3y)5.61%
ROA(5y)7.93%
ROE(3y)13.8%
ROE(5y)18.59%
ROIC(3y)11.59%
ROIC(5y)14.22%
ROICexc(3y)12.35%
ROICexc(5y)15.17%
ROICexgc(3y)83.03%
ROICexgc(5y)N/A
ROCE(3y)13.49%
ROCE(5y)16.56%
ROICexgc growth 3Y-36.88%
ROICexgc growth 5Y-17.49%
ROICexc growth 3Y-16.79%
ROICexc growth 5Y-8.38%
OM growth 3Y-5.09%
OM growth 5Y-0.99%
PM growth 3Y-10.68%
PM growth 5Y-2.66%
GM growth 3Y1.23%
GM growth 5Y0.68%
F-Score9
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 2.74
Debt/EBITDA 2.16
Cap/Depr 44.05%
Cap/Sales 1.41%
Interest Coverage 250
Cash Conversion 88.91%
Profit Quality 154.69%
Current Ratio 1.61
Quick Ratio 1.19
Altman-Z 3.89
F-Score9
WACC9.01%
ROIC/WACC1.19
Cap/Depr(3y)40.17%
Cap/Depr(5y)39.59%
Cap/Sales(3y)1.46%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.25%
EPS 3Y-3.25%
EPS 5Y4.34%
EPS Q2Q%8.25%
EPS Next Y12.75%
EPS Next 2Y11.66%
EPS Next 3Y14.19%
EPS Next 5Y17.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%10.57%
Revenue Next Year9.76%
Revenue Next 2Y7.61%
Revenue Next 3Y6.32%
Revenue Next 5Y11.65%
EBIT growth 1Y28.14%
EBIT growth 3Y-8.88%
EBIT growth 5Y1.11%
EBIT Next Year24.74%
EBIT Next 3Y14.92%
EBIT Next 5Y13.71%
FCF growth 1Y1484%
FCF growth 3Y-1.88%
FCF growth 5Y8.86%
OCF growth 1Y609.84%
OCF growth 3Y-1.78%
OCF growth 5Y8.14%

ZEBRA TECHNOLOGIES CORP-CL A / ZBRA FAQ

Can you provide the ChartMill fundamental rating for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a fundamental rating of 5 / 10 to ZBRA.


Can you provide the valuation status for ZEBRA TECHNOLOGIES CORP-CL A?

ChartMill assigns a valuation rating of 7 / 10 to ZEBRA TECHNOLOGIES CORP-CL A (ZBRA). This can be considered as Undervalued.


How profitable is ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) stock?

ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) has a profitability rating of 7 / 10.


How financially healthy is ZEBRA TECHNOLOGIES CORP-CL A?

The financial health rating of ZEBRA TECHNOLOGIES CORP-CL A (ZBRA) is 5 / 10.